HeartBeam, Inc. (BEAT) 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated June 12, 2024, details the results of HeartBeam, Inc.'s Annual Meeting of Stockholders held virtually on that date. The Company is an emerging growth company incorporated in Delaware with principal executive offices in Santa Clara, California.
Key Financial Metrics
This filing is a corporate governance report and does not contain financial performance data. The text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes and Voting Results
As of the record date (April 15, 2024), 26,329,032 shares of Common Stock were outstanding. Approximately 58.91% of outstanding votes were represented at the meeting, constituting a quorum. The following matters were voted upon:
- Election of Directors: All eight nominees were elected to serve one-year terms. Notable voting patterns included significant "Against" votes for Richard Ferrari (1,208,286) and George A. de Urioste (1,241,931), while Michael Jaff received the fewest "Against" votes (3,868).
- Ratification of Auditors: The proposal to ratify Marcum LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, was approved with 15,480,741 votes "For" and only 5,967 "Against."
- Equity Incentive Plan Amendment: The proposal to amend the 2022 Equity Incentive Plan to increase authorized shares from 5,900,000 to 8,900,000 was approved. This proposal received 6,690,616 votes "For" and 1,853,898 votes "Against."
Guidance, Outlook, and Risks
The filing does not contain management commentary on future guidance, outlook, specific risks, or contingencies beyond the standard disclosure of the voting results and the submission of the amended Equity Incentive Plan as an exhibit.
Key Facts for Investor Verification
- Verify the specific reasons for the significant "Against" votes cast for directors Richard Ferrari and George A. de Urioste, which exceeded 1.2 million votes each.
- Confirm the impact of the approved increase in the 2022 Equity Incentive Plan (from 5.9M to 8.9M shares) on potential future dilution.
- Review the full text of the Second Amendment to the 2022 Equity Incentive Plan (Exhibit 10.1) for specific terms regarding vesting and eligibility.
- Note that this filing contains no financial data; refer to the most recent 10-K or 10-Q for financial performance metrics.